Orthopedic shoes sales will strengthen through 2036, anchored by flatfoot orthopedic shoes at 28.4% of the product segment in 2026. Foot disorder applications account for 41.2% of the application segment. The market is expected to reach USD 4.8 million by the end of 2026 and USD 11.7 million by 2036.